Neuropacs™ Corp., an innovator in AI-enabled neurological imaging, today announced that the U.S. Food and Drug Administration has granted De Novo classification to neuropacs™, a diffusion MRI-based ...

Inaccurate social media posts about attention deficit hyperactivity disorder (ADHD) and autism are linked to a rise in young ...

Visual BCIs based on steady-state visual evoked potentials (SSVEPs) have long been the gold standard for high-speed noninvasive brain-computer ...

Modern neuroscience has transitioned from small-scale manual observations to a data-intensive field powered by computational innovation. Traditionally ...

A research team at Tohoku University and Future University Hakodate has demonstrated that living biological neurons can be ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The ...

India’s first clinical guidelines on micronutrients highlight the critical role of vitamins and minerals in patient recovery, ...

Q4 2025 Earnings Call March 30, 2026 4:30 PM EDTCompany ParticipantsPanna Sharma - President, CEO & DirectorDavid Margrave ...

A gene therapy called AMT-130 appears to be the first treatment to slow the progression of Huntington’s disease, an inherited and fatal neurological disorder that has resisted every previous attempt ...

Voice-based depression detection startup Kintsugi is shutting down after failing to secure FDA clearance, open-sourcing its AI technology instead.

Experts developed a validated multidisciplinary algorithm for diagnosing and treating pelvic venous disorders, using a Delphi consensus process.

This is a potentially important study comparing infants (8 months) and adults with respect to rhythmic EEG response properties during periodic and aperiodic visual stimulation. The results provide ...